GSK Resumes Shipment Of Paxil CR, Plans 30-Day Free Trial Program To Relaunch

Paxil CR is back on pharmacy shelves after compliance concerns kept the antidepressant out of production for four months. The company expects to return Avandamet to the market within two weeks. FDA seized all lots of the products in March.